Juliet Bakker Tammenoms

Affiliations

  • at Rxsight Inc. (RXST), 2024-02-15
  • Large Shareholder at Lexeo Therapeutics Inc. (LXEO), 2023-11-10
  • Large Shareholder at Vera Therapeutics Inc. (VERA), 2023-02-09
  • Large Shareholder at Sierra Oncology Inc. (SRRA), 2022-04-29
  • Large Shareholder at Inozyme Pharma Inc. (INZY), 2022-04-21
  • Large Shareholder at Rapid Micro Biosystems Inc. (RPID), 2021-07-21
  • Large Shareholder, Director at Eargo Inc. (EAR), 2021-05-19
  • Large Shareholder at Talaris Therapeutics Inc. (TALS), 2021-05-11
  • Large Shareholder at 89Bio Inc. (ETNB), 2020-11-19
  • Director at Axonics Modulation Technologies Inc. (AXNX), 2020-09-22
  • Large Shareholder at Molecular Templates Inc. (MTEM), 2020-09-01
  • Large Shareholder at Vaxcyte Inc. (PCVX), 2020-06-11
  • Other at Venus Concept Inc. (VERO), 2020-03-05
  • at Tricida Inc. (TCDA), 2018-07-03
  • Large Shareholder at Aptinyx Inc. (APTX), 2018-06-26
  • Large Shareholder at Aimmune Therapeutics Inc. (AIMT), 2018-02-26
  • Large Shareholder at Collegium Pharmaceutical Inc (COLL), 2017-12-12
  • Large Shareholder at Kala Pharmaceuticals Inc. (KALA), 2017-07-27
  • Large Shareholder at Corcept Therapeutics Inc (CORT), 2016-12-19
  • Large Shareholder at Esperion Therapeutics Inc. (ESPR), 2014-11-19
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
RXST $51.29 4,000 29,840 2024-02-14 Filing
RXST $50.38 4,000 25,840 2024-02-12 Filing
RXST $12.50 480,000 Director 980,000 2023-02-10 Filing
RXST $16.00 500,000 Director 500,000 2021-08-03 Filing
RXST $16.00 125,000 Director 1,988,613 2021-08-03 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
RXST $29.77 349,245 0 2023-11-29 Filing
RXST $29.62 145,068 349,245 2023-11-28 Filing
RXST $27.20 400,000 494,313 2023-11-15 Filing
RXST $27.13 100,000 894,313 2023-11-14 Filing
RXST $30.01 2,950 20,223 2023-09-11 Filing